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Abstract We report here the identi¢cation of the homologous
gene pair ZDS1,2 as multicopy suppressors of a temperature-
sensitive allele (cka2-13ts) of the CKA2 gene encoding the KP
catalytic subunit of protein kinase CK2. Overexpression of
ZDS1,2 suppressed the temperature sensitivity, geldanamycin
(GA) sensitivity, slow growth, and £occulation of multiple
cka2 alleles and enhanced CK2 activity in vivo toward a known
physiological substrate, Fpr3. Consistent with the existence of a
recently described positive feedback loop between CK2 and
Cdc37, overexpression of ZDS1,2 also suppressed the temper-
ature sensitivity, abnormal morphology, and GA sensitivity of a
CK2 phosphorylation-de¢cient mutant of CDC37, cdc37-S14A,
as well as the GA sensitivity of a cdc37-1 allele. A likely basis
for all of these e¡ects is our observation that ZDS1,2 overex-
pression enhances Cdc37 protein levels. Activation of the pos-
itive feedback loop between CK2 and Cdc37 likely contributes
to the pleiotropic nature of ZDS1,2, as both CK2 and Cdc37
regulate diverse cellular functions.
* 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Protein kinase CK2 is a ubiquitous serine/threonine kinase
of unknown function (for reviews, see [1^4]). The enzyme is
composed of catalytic K (35^44 kDa) and regulatory L (24^28
kDa) subunits that combine to form an K2L2 tetramer. In
Saccharomyces cerevisiae, the enzyme consists of two distinct
catalytic subunits, K and KP (encoded by CKA1 and CKA2,
respectively), and two regulatory subunits, L and LP (encoded
by CKB1 and CKB2, respectively). CK2 recognizes Ser/Thr
(or in exceptional cases Tyr; [5]) in an acidic environment
and phosphorylates a broad spectrum of endogenous sub-
strates involved in transcription, translation, signal transduc-
tion, and other functions [6].
The S. cerevisiae ZDS1 and/or 2 genes have been isolated in
a bewildering variety of genetic screens (for review see [7]).
Genes identi¢ed in these screens include: CDC42, encoding a
Rho family GTPase required for cell polarity [7] ; CDC28,
which encodes the central cell division cycle kinase of S. ce-
revisiae [8] ; CEG1, encoding the guanylyltransferase respon-
sible for mRNA capping [9] ; SIN4, which plays a global role
in chromatin structure [8] ; as well as several other genes in-
volved in multiple processes [10^13]. The diverse nature of
these genetic interactions was the basis for naming this gene
pair ZDS1 and ZDS2 (zillion di¡erent screens 1 and 2; [7]).
In spite of the diversity of their interactions, ZDS1,2 appear
to be intimately involved in some aspect/s of cell polarity.
First, a strain bearing a deletion of both ZDS1 and ZDS2
has elongated, abnormally shaped buds with hyperpolarized
actin [7^9]. Second, epitope-tagged Zds1 localizes to presump-
tive bud sites, the apex of developing buds, and the mother^
bud junction of large-budded cells [7]. Third, Zds1,2 have
recently been reported to physically interact with diverse
gene products involved in cell polarity [14]. The basis for
the bewildering array of genetic interactions involving
Zds1,2 remains obscure, however. We have recently reported
that a positive feedback loop between CK2 and Cdc37 pro-
motes the activity of multiple cellular kinases involved in di-
verse functions [15]. We now present evidence to show that
ZDS1,2 overexpression augments the function of both CK2
and Cdc37, thus providing a possible explanation for the
pleiotropic nature of ZDS1,2, since both CK2 and Cdc37
regulate diverse cellular processes.
2. Materials and methods
2.1. Strains and growth media
S. cerevisiae strains used in this study are listed in Table 1 [8,15,16].
Yeast strains were grown in rich glucose medium (YPD: 1% yeast
extract, 2% peptone, and 2% glucose) or in YPD medium supple-
mented with geldanamycin (GA) at 35 WM at di¡erent temperatures
as indicated in ¢gure legends. GA (Sigma) was dissolved in dimethyl-
sulfoxide and added directly to warm medium. Escherichia coli strain
DH5K (Clontech) was grown in Luria broth containing 50 Wg/ml
ampicillin.
2.2. Strain manipulations and cell biology
Transformations and other genetic manipulations were carried out
using standard yeast procedures [17]. Disruption of the SWE1 gene
was carried out by polymerase chain reaction-mediated gene replace-
ment [18]. For morphological observations, indicated strains were
grown to mid-log phase at 23‡C and ¢xed by addition of formalde-
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hyde to a ¢nal concentration of 3.7%. Cell morphology was visualized
using Nomarski optics.
Flocculation was assayed as described previously [19] except that
the cultures were grown in selective liquid medium to reduce variation
in £occulation values.
2.3. ZDS1 mutagenesis
ZDS1(1-358) was prepared by introducing a GAA-to-TAA muta-
tion at position 359 using the mutagenic oligonucleotide 5P-CCAT-
GACATGGCCTTAACGATCGTGAC-3P. The AlwN1 selection oli-
gonucleotide (Stratagene) was used as the selection oligonucleotide.
Mutagenesis was con¢rmed by sequencing. Zds1v625-809 was pro-
duced by removal of the internal 555 nucleotide HindIII fragment
of ZDS1.
2.4. CK2 assays and Western blotting
To assay for steady-state Tyr-phosphorylation of Fpr3, the relevant
strains were grown at the indicated temperatures to mid-log phase.
Five A600 units of each culture were pelleted by centrifugation,
brought to a ¢nal volume of 100 Wl, and stored at 380‡C for Western
analysis. Samples were processed for Western blotting as described
elsewhere [15]. Mouse monoclonal anti-Cdc37 (gift from Avrom Cap-
lan, Mt. Sinai Medical Center) was used at 1:1500, mouse anti-phos-
photyrosine antibody 4G10 (Upstate Biotechnology) at 1:1000, and
rabbit anti-Fpr3 (gift of Jeremy Thorner, University of California,
Berkeley, CA, USA) at 1:1000. Immunodetection was performed us-
ing the Ampli¢ed Alkaline Phosphatase Immun-Star1 kit (Bio-Rad).
3. Results
A genetic screen was conducted to isolate multicopy sup-
pressors of the temperature sensitivity of a cka2-13 allele at
35‡C. In addition to CDC37 [15], we also isolated ZDS1 as a
multicopy suppressor of cka2 mutants. As shown in Fig. 1A,
overexpression of ZDS1 suppressed cka2-13 at 35‡C, but not
at 37‡C. The introduction of a stop codon at position 359 of
the Zds1 open reading frame inactivated suppressor function,
con¢rming the identi¢cation of ZDS1 as the relevant gene. An
in-frame HindIII deletion construct was fully active as a sup-
pressor, indicating that residues 625^809 are dispensable for
suppressor function. Overexpression of ZDS1 or CDC37 also
suppressed the £occulation (Fig. 1B) and slow-growth pheno-
type (data not shown) of multiple cka2 alleles. Although
ZDS1 overexpression did not suppress the £occulation phe-
notype of cka2-11 (Fig. 1B), it did suppress its temperature
sensitivity and slow-growth phenotype. Multicopy Zds1 was
unable to suppress a null (data not shown), indicating that it
does not bypass the requirement for CK2. The Zds1 homolog,
ZDS2, was also tested and found to be able to suppress cka2-




YDH6 MATa ade2-101 his3-v200 leu2-v1 lys2-801 trp1-v1 ura3-52 cka1-v1: :HIS3 cka2-v1: :TRP1 [pRS315 CKA2] [16]
YDH8 MATa ade2-101 his3-v200 leu2-v1 lys2-801 trp1-v1 ura3-52 cka1-v1: :HIS3 cka2-v1: :TRP1 [pRS315 cka2-8] [16]
YDH11 MATa ade2-101 his3-v200 leu2-v1 lys2-801 trp1-v1 ura3-52 cka1-v1: :HIS3 cka2-v1: :TRP1 [pRS315 cka2-11] [16]
YDH13 MATa ade2-101 his3-v200 leu2-v1 lys2-801 trp1-v1 ura3-52 cka1-v1: :HIS3 cka2-v1: :TRP1 [pRS315 cka2-13] [16]
YRM14.0 MATa his3-v200 leu2-v1 trp1-v63 ura3-52 cdc37-1 [15]
YSB11 MATa leu2 ura3 trp1 cdc37v : :LEU2 [pRS314 CDC37] [15]
YSB13 MATa leu2 ura3 trp1 cdc37v : :LEU2 [pRS314 cdc37-S14A] [15]
YSB15 MATa leu2 ura3 trp1 cdc37v : :LEU2 [pRS314 cdc37-S14,17E] [15]
YSB49 MATa ade2-101 his3-v200 leu2-v1 lys2-801 trp1-v1 ura3-52 cka1-v1: :HIS3 cka2-v1: :TRP1 ptp1: :kanMX4
[pRS315 cka2-13]
[15]
DY3143 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 ssd1-d1 trp1-1 ura3-1 zds1: :URA3 zds2: :TRP1 [8]
YSB27 MATa leu2 ura3 trp1 cdc37v : :LEU2 swe1v : :kanMX4 [pRS314 cdc37-S14,17E] This study
YSB28 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 ssd1-d1 trp1-1 ura3-1 zds1: :URA3 zds2: :TRP1 swe1v : :kanMX4 This study
Fig. 1. Multicopy suppression of cka2ts by ZDS1 and CDC37.
A: E¡ect of multicopy ZDS1 alleles on the temperature sensitivity
of cka2-13. Strains used in order were YDH6 (cka1v CKA2) trans-
formed with pRS426 and YDH13 (cka1v cka2-13ts) transformed
with pRS426 or pRS426 expressing ZDS1, ZDS1-(v625-809), or
ZDS1-(1-358). B: E¡ect of multicopy ZDS1 and CDC37 on the
£occulation phenotype associated with three cka2ts alleles. Strains
YDH6 (cka1v CKA2), YDH8 (cka1v cka2-8ts), YDH11 (cka1v
cka2-11ts), and YDH13 (cka1v cka2-13ts) were transformed with
pRS426 (1), pRS426-ZDS1 (2), or with pRS426-CDC37 (3).
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Overexpression of ZDS1,2 might suppress cka2-13 strains
either by stimulating residual CK2 activity or by decreasing
the cellular requirement for CK2. We have previously shown
that cka2-13 mutants are sensitive to the Hsp90-speci¢c inhib-
itor GA and that overexpression of CDC37 suppresses this
sensitivity by promoting CK2 activity [15]. As shown in Fig.
2A, overexpression of either ZDS1 or ZDS2 suppressed the
GA sensitivity of a cka2-13 mutant, suggesting a role for ZDS
in maintaining or enhancing CK2 activity. The level of sup-
pression observed is comparable to that seen with CDC37
(Fig. 2A). As a more direct measure of the e¡ect of ZDS1
overexpression on CK2 activity, we monitored tyrosine phos-
phorylation of Fpr3 as an indicator of CK2 activity in vivo.
CK2 speci¢cally catalyzes tyrosine phosphorylation of Fpr3, a
nuclear immunophilin, on Tyr184, and this phosphorylation is
reversed by the protein tyrosine phosphatase encoded by
PTP1 [5]. In a ptp1v background, phosphorylated Fpr3 rep-
resents a major band in a Western blot of whole cell extract
probed with anti-P-Tyr antibody. As shown in Fig. 2B, a
cka2-13 ptp1v strain arrests at 35‡C with very little Tyr-phos-
phorylated Fpr3 and has only marginally higher activity to-
ward Fpr3 at 33‡C, a semipermissive temperature for this
mutant. ZDS1 overexpression (at 33‡C) increases the relative
amount of Tyr-phosphorylated Fpr3 to a level approximately
equal to that seen in the mutant at permissive temperature (all
lanes in Fig. 2B contain comparable levels of Fpr3 protein;
data not shown). Thus, overexpression of Zds1 enhances CK2
activity.
We have recently reported the existence of a positive feed-
back loop between protein kinase CK2 and the protein ki-
nase-speci¢c chaperone, Cdc37 [15]. Hence, we wished to
test if ZDS1,2 might stimulate CK2 activity in a cka2-13
strain by enhancing Cdc37 function. Consistent with such a
possibility, we found that overexpression of ZDS1 or ZDS2
was able to suppress the temperature sensitivity (Fig. 3A) and
also the abnormal morphology (Fig. 3B) of cdc37-S14A, an
allele of CDC37 in which the evolutionarily conserved CK2
phosphorylation site at serine-14 has been mutated to an ala-
nine. Unlike the wild-type protein, Cdc37-S14A is de¢cient in
promoting the activity of multiple protein kinases, including
CK2 [15]. Although impaired in Cdc37 function, cdc37-S14A
overexpression suppressed the temperature sensitivity of this
strain more e⁄ciently than did ZDS1,2 overexpression (Fig.
3A). The signi¢cance of this result is discussed below. As
shown in Fig. 3B, ZDS1,2 overexpression also suppressed
the abnormal morphology of cdc37-S14,17E, an allele in
Fig. 2. ZDS1,2 overexpression suppresses GA sensitivity of cka2-13
and enhances CK2 activity toward Fpr3 in vivo. A: YDH13 (cka1v
cka2-13ts) transformed with pRS426 or pRS426 expressing CDC37,
ZDS1, or ZDS2 was spotted at 5000 cells/spot on YPD or YPD
supplemented with GA (35 WM) and incubated at 21‡C or 30‡C for
3 days. B: YDH13 transformed with pRS426 or pRS426-ZDS1 was
grown at permissive temperature (26‡C) or semipermissive tempera-
ture (33‡C). Half of the culture grown at 26‡C was shifted to non-
permissive temperature (35‡C) for 3 h. Identical amounts of cell ly-
sates were probed with anti-P-Tyr antibody (4G10 at 1:1000 dilu-
tion) to assay for levels of phosphorylated Fpr3 as a measure of
CK2 activity in vivo.
Fig. 3. Multicopy suppression of cdc37 mutants by ZDS1,2.
A: ZDS1,2 overexpression suppresses the temperature sensitivity of
cdc37-S14A. YSB11 (CDC37) transformed with pRS426 or YSB13
(cdc37-S14A) transformed with pRS426 or with pRS426 expressing
cdc37-S14A, ZDS1, or ZDS2 was spotted at 5000 cells/spot and
grown at the indicated temperatures for 3 days before being photo-
graphed. B: ZDS1,2 overexpression suppresses abnormal bud mor-
phology of cdc37-S14A or cdc37-S14,17E. YSB13 (cdc37-S14A) and
YSB15 (cdc37-S14,17E) bearing relevant overexpression plasmids as
indicated were grown at 27‡C to mid-log phase, and photographs of
cells were taken on a Zeiss IM 35 epi£uorescence microscope ¢tted
with Nomarski optics.
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which both serine-14 and an additional CK2 consensus site at
serine-17 are replaced by glutamate, which partially restores
Cdc37 function [15].
We next sought to test the role of Hsp90 in the genetic
interaction between ZDS1,2 and CDC37. For this, we again
exploited the fact that cdc37 mutants are hypersensitive to the
Hsp90-speci¢c inhibitor GA [15]. As shown in Fig. 4A, both
cdc37-1, which encodes a C-terminal truncation of approxi-
mately the last third of the protein [20], and cdc37-S14A are
hypersensitive to GA (35 WM). Overexpression of either ZDS1
or ZDS2 was able to partially suppress the GA sensitivity of
both the cdc37 mutants tested (Fig. 4A). We independently
tested whether Zds1,2 could enhance Hsp90 function, and
found that ZDS1,2 overexpression did not suppress either
the temperature sensitivity of hsp90G170D or hsp90T22I mu-
tants or the GA sensitivity of hsf1-1 mutants (which are GA
sensitive because of reduced Hsp90 function), nor did over-
expression of HSP82 or HSC82 (which encode the yeast
Hsp90 isoforms) suppress the temperature sensitivity of
cdc37-1 or cdc37-S14A (data not shown). Thus, our results
indicate that Hsp90 is not critical for the genetic relationship
between Zds1,2 and Cdc37. These data also indicate that this
interaction is not speci¢c to CK2 phosphorylation site mu-
tants of Cdc37.
Western blot analysis revealed that overexpression of
ZDS1,2 in cdc37-S14A resulted in an increased steady-state
level of Cdc37-S14A protein, though this increase was less
than that attained upon overexpression of cdc37-S14A itself
in the same strain background (Fig. 4B). These data coincide
well with the enhanced suppression achieved upon overexpres-
sion of cdc37-S14A versus the suppression achieved by over-
expression of ZDS1,2 (Fig. 3A). Thus, we conclude that over-
expression of ZDS1,2 in cdc37-S14A achieves suppression by
increasing the steady-state level (and hence function) of the
partially functional, mutant Cdc37 protein. ZDS1,2 overex-
pression was found to enhance Cdc37 levels in a cka2-13
strain as well (data not shown).
SWE1 encodes a protein kinase that plays a pivotal role in
S. cerevisiae morphogenesis by negatively regulating Cdc28-
Clb activity [21,22]. Interestingly, the hyperpolarized pheno-
type of zds1v zds2v strains is e⁄ciently reversed by deletion
of the SWE1 gene or by mutations of the Cdc28 kinase that
render the protein SWE1 independent [10^12,23]. Consistent
with these reports, we ¢nd that SWE1 deletion completely
suppresses the abnormal morphology of a zds1v zds2v mutant
(Fig. 5). Moreover, ZDS1,2 overexpression inhibits the hyper-
polarized morphology seen upon SWE1 overexpression (data
not shown). Thus, ZDS1,2 behaves genetically as a negative
regulator of SWE1 function. Because of the genetic interac-
tions among ZDS1,2, CDC37, and CK2, we asked whether
the abnormal morphology of cdc37 and/or CK2 mutants
might also be SWE1 dependent. As shown in Fig. 5, deletion
of SWE1 completely suppressed the abnormal morphology of
cdc37-S14,S17E, consistent with the activation of Cdc28 by
Cdc37 [20] and its inhibition by Swe1. Given the interactions
described above, Zds could potentially e¡ect Cdc28 kinase
activity via both proteins simultaneously. In contrast, SWE1
deletion did not suppress any abnormality associated with
cka2-13 mutants (data not shown). The latter result indicates
that the interaction between ZDS1 and CK2 does not result
from inhibition of Swe1 by Zds1.
4. Discussion
We report here that ZDS1,2 overexpression results in stim-
ulation of both nodes of a recently reported, positive feedback
Fig. 4. ZDS1,2 overexpression increases Cdc37 protein levels.
A: YRM14.0 (cdc37-1) and YSB13 (cdc37-S14A) were transformed
with pRS426 or pRS426 expressing CDC37, ZDS1, or ZDS2 and
spotted on YPD or YPD supplemented with GA (35 WM). Plates
were incubated at 27‡C (cdc37-1) or 30‡C (cdc37-S14A) for 3 days.
B: YSB11 (CDC37) transformed with pRS426 or YSB13 (cdc37-
S14A) transformed with pRS426 or pRS426 expressing ZDS1,
ZDS2, or cdc37-S14A was grown to mid-log phase at 27‡C, and
parallel immunoblots of cell lysates were probed with mouse mono-
clonal anti-Cdc37 and anti-Fpr3 as a loading control.
Fig. 5. Abnormal bud morphology of cdc37-S14,17E and zds1v
zds2v is SWE1-dependent. YSB15 (cdc37-S14,17E), YSB27 (cdc37-
S14,17E swe1v), DY3143 (zds1v zds2v), and YSB28 (zds1v zds2v
swe1v) were grown at 27‡C to mid-log phase in minimal medium
and photographed with Nomarski optics.
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loop between protein kinase CK2 and the protein kinase-spe-
ci¢c chaperone, Cdc37 [15]. Given the numerous substrates of
CK2 and the diverse clients of Cdc37, activation of the feed-
back loop between these two proteins may contribute to the
pleiotropic interactions displayed by ZDS in S. cerevisiae. We
hasten to add, however, that although ZDS1,2 enhance CK2
activity and Cdc37 function in S. cerevisiae when overex-
pressed, zds1v zds2v mutants exhibit no de¢cit in either
CK2 activity toward Fpr3 or Cdc37 protein levels (S. Band-
hakavi and C.V.C. Glover, unpublished). It thus appears un-
likely that ZDS represents a physiological regulator of the
positive feedback loop between these two proteins.
Because of the existence of the positive feedback between
CK2 and Cdc37, it is not currently possible to state unequiv-
ocally which of the two proteins (or both) is the target of
ZDS. However, coupled with our earlier identi¢cation of
CK2 as a Cdc37 client [15], the observation that ZDS over-
expression increases Cdc37 protein level (Fig. 4B) suggests a
model in which ZDS overexpression elevates the steady-state
abundance of Cdc37, which in turn stimulates CK2 activity.
While additional and possibly direct e¡ects of ZDS on CK2
activity cannot be rigorously excluded, the excellent correla-
tion observed between Cdc37-S14A abundance (Fig. 4B) and
the extent of ZDS suppression of cdc37-S14A (Fig. 3A) sug-
gests that such mechanisms, if they exist, may be minor.
How might ZDS act to regulate Cdc37 abundance? The
absence of allele speci¢city in the genetic interactions between
CDC37 and ZDS1,2 provides no evidence for a physical in-
teraction between the two proteins. Consistent with this, we
were unable to detect a two-hybrid interaction between Zds1
and Cdc37 (or between either of these proteins and any of the
four subunits of yeast CK2) (S. Bandhakavi and C.V.C. Glo-
ver, unpublished). Given that ZDS1,2 suppress mutants of
eukaryotic translational initiation factor eIf4A in yeast [9],
one possibility is that ZDS enhances the translation of
Cdc37 mRNA. Alternatively, ZDS might inhibit Cdc37 deg-
radation. The ability of ZDS to function as a negative regu-
lator of SWE1 (Fig. 5) [10^12,23] may be of relevance in the
latter regard, as degradation of Swe1 is pivotal to its function
in G2/M cell cycle progression and the morphogenesis check-
point [21]. Interestingly, deletion of either HSL1 or HSL7,
which are required for Swe1 degradation [24^26], yields a
phenotype very similar to that of a zds1 zds2 strain, and
this phenotype is also e⁄ciently suppressed by ZDS overex-
pression [11]. Although negative regulation of SWE1 tran-
scription by ZDS has been proposed to account for these
e¡ects [11], a role for ZDS in promoting Swe1 degradation
would also be consistent with the observations. If the genetic
interactions of ZDS with CDC37 and SWE1 are indeed medi-
ated via an e¡ect on protein turnover, clearly ZDS must act
di¡erently in the two cases, inhibiting degradation of Cdc37
but promoting degradation of Swe1.
No biochemical function for Zds has yet been de¢ned, and
the protein sequence contains no informative motifs. How-
ever, a recent screen for protein complexes in S. cerevisiae
using a⁄nity puri¢cation and mass spectrometry [27] provides
some intriguing clues. In contrast to two-hybrid results indi-
cating multiple interactions between Zds1 or 2 and cell polar-
ity proteins [14], this screen identi¢ed both Zds1 and 2 as
components of a multiprotein complex (complex 151) contain-
ing virtually all of the known subunits of protein phosphatase
2A (PP2A), including Cdc55, Pph21, Pph22, Rts1, and Tpd3,
as well as multiple subunits of the proteasome. The associa-
tion of Zds with PP2A is intriguing, as a role for Zds in
regulation and/or targeting of this protein phosphatase could
contribute to the pleiotropic genetic interactions of ZDS. Re-
markably, cdc55 or tpd3 strains display an elongated mor-
phology that is strikingly similar to that of a zds1 zds2 mu-
tant, and this phenotype is likewise suppressed by a SWE1-
resistant allele of CDC28 [10]. The presence of proteasome
subunits in the complex is also intriguing in view of the im-
portance of protein phosphorylation/dephosphorylation in
targeting proteins for ubiquitin-mediated degradation. Future
studies will be necessary to con¢rm a role for Zds1 and 2 in
proteasome-mediated protein degradation and to determine
whether PP2A activity is involved in this process.
Computer-based searches of completed eukaryotic genomes
reveal that a ZDS ortholog is present in diverse fungal species,
but absent in plants or metazoans (C.V.C. Glover, unpub-
lished), suggesting a fungal-speci¢c role. Given the importance
of ZDS to cell polarity and morphogenesis in S. cerevisiae and
the crucial role of morphology in fungal pathogenesis, ZDS
may represent an attractive target for development of antifun-
gal agents.
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